Quality and regulatory affairs
Pharmaceuticals

Quality and regulatory affairs

Bandeau1

QUALITY WITH PATIENT SAFETY IN MIND

“Novasep operates a high-performance quality management system compliant with current Good Manufacturing Practices (cGMP). Our teams are dedicated and conduct continuous upgrades to ensure that all Novasep plants meet the highest level of compliance with ever stricter regulatory standards.”
Jean-Claude Romain, Sr VP Quality at Novasep.

All our cGMP production facilities are regularly audited by our customers and all applicable regulatory bodies including the US FDA, local authorities and where applicable, Japan PMDA. All manufacturing facilities have been inspected by the FDA in 2013-2014 and successfully passed the inspection without any major observations.

Novasep Quality Control

This robust quality system relies on several cornerstones: compliance with regulatory and customer requirements, risk management principles, continuous improvement through the monitoring of key performance indicators (KPIs) and their review by the management. Compliance with regulatory requirements is also assessed during the numerous customer and internal audits carried out each year. Above all, top-quality arises from the daily commitment of all staff involved in manufacturing activities: they know that beyond regulatory compliance, patient safety is what really matters.

A RECOGNIZED EXPERTISE IN THE HANDLING OF HIGHLY POTENT COMPOUNDS

Good practices in the manufacture and handling of HPAPIs results from experience and smart consideration of the process as a whole. We combine pragmatic and rigorous approaches to all disciplines including equipment and facility design, process design and development as well as process validation. We ensure that our activities fully guarantee the safety of patients and employees.

Get more details on the management of EH&S aspects for cytotoxics and highly potent compounds at Novasep.

REGULATORY SUPPORT SERVICES

Novasep has a dedicated regulatory team to provide the regulatory support and expertise required for the submission and maintenance of regulatory filings. Novasep can assist customers in drafting and submitting the CMC section of IMPDS, INDs, MAAs and NDAs; we can also file and maintain our own CEPs, ASMFs and DMFs.
Novasep has filed regulatory dossiers for about 40 APIs and formulations and manage approximately 200 DMFs and ASMFs with different authorities worldwide (the USA, Europe, Canada, Japan, Korea, etc.).
Our full quality and inspection track record is available upon request, contact us for more details or to assess you regulatory support needs

Downloads
  • Global offer for pharmaceuticals
    Global offer for pharmaceuticals
    size: 304.1K
    date: 08/12/2014
  • Low temperature chemistry
    Low temperature chemistry
    size: 209.2K
    date: 08/12/2014
  • ADC Brochure
    ADC Brochure
    size: 672.1K
    date: 20/10/2015
Contact
You can stay on this page and select more documents or you can directly download the brochure(s) you selected